Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $162.2100 (-2.18%) ($162.0100 - $162.2100) on Mon. Mar. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.1% (three month average) | RSI | 63 | Latest Price | $162.2100(-2.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 3.1% a day on average for past five trading days. | Weekly Trend | LGND advances 3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(58%) IWM(55%) IWC(53%) XBI(53%) | Factors Impacting LGND price | LGND will decline at least -2.55% in a week (0% probabilities). VIXM(-27%) UUP(-18%) VXX(-17%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.55% (StdDev 5.1%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $157.13(3.23%) | 10 Day Moving Average | $151.66(6.96%) | 20 Day Moving Average | $149.83(8.26%) | To recent high | -24.8% | To recent low | 69.5% | Market Cap | $2.607b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |